
Interpace Biosciences Inc is a diagnostics & research business based in the US. Interpace Biosciences shares (IDXG) are listed on the OTCQX (a marketplace for buying and selling "over the counter" stocks which aren't listed on a formal stock exchange) and all prices are listed in US Dollars. Interpace Biosciences employs 147 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Interpace Biosciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – IDXG – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Interpace Biosciences stock price (OTCQX: IDXG)
Use our graph to track the performance of IDXG stocks over time.Interpace Biosciences shares at a glance
Latest market close | $3.20 |
---|---|
52-week range | $2.76 - $10.50 |
50-day moving average | $3.54 |
200-day moving average | $5.91 |
Wall St. target price | $11.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-3.12 |
Buy Interpace Biosciences shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Interpace Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Interpace Biosciences price performance over time
Historical closes compared with the close of $3.2 from 2022-07-01
1 week (2022-06-28) | -4.48% |
---|---|
1 month (2022-06-06) | -11.11% |
3 months (2022-04-06) | -36.00% |
6 months (2022-01-06) | -62.35% |
1 year (2021-07-06) | -68.63% |
---|---|
2 years (2020-07-06) | -49.69% |
3 years (2019-07-05) | 350.70% |
5 years (2017-07-05) | 232.54% |
Interpace Biosciences financials
Revenue TTM | $41.9 million |
---|---|
Gross profit TTM | $17.9 million |
Return on assets TTM | -16.91% |
Return on equity TTM | -161.49% |
Profit margin | -31.02% |
Book value | $0.42 |
Market capitalisation | $14.5 million |
TTM: trailing 12 months
Interpace Biosciences share dividends
We're not expecting Interpace Biosciences to pay a dividend over the next 12 months.
Have Interpace Biosciences's shares ever split?
Interpace Biosciences's shares were split on a 1:10 basis on 14 January 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Interpace Biosciences shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Interpace Biosciences shares which in turn could have impacted Interpace Biosciences's share price.
Interpace Biosciences share price volatility
Over the last 12 months, Interpace Biosciences's shares have ranged in value from as little as $2.755 up to $10.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (OTCQX average) beta is 1, while Interpace Biosciences's is 1.2872. This would suggest that Interpace Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Interpace Biosciences overview
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; PanDNA, a molecular only version of PancraGEN that provides physicians a snapshot of a limited number of factors; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company also provides pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. It primarily serves physicians, hospitals, and clinics. The company was formerly known as Interpace Diagnostics Group, Inc.
Frequently asked questions
What percentage of Interpace Biosciences is owned by insiders or institutions?Currently 27.114% of Interpace Biosciences shares are held by insiders and 0.007% by institutions. How many people work for Interpace Biosciences?
Latest data suggests 147 work at Interpace Biosciences. When does the fiscal year end for Interpace Biosciences?
Interpace Biosciences's fiscal year ends in December. Where is Interpace Biosciences based?
Interpace Biosciences's address is: Morris Corporate Center 1, Parsippany, NJ, United States, 07054 What is Interpace Biosciences's ISIN number?
Interpace Biosciences's international securities identification number is: US46062X3035 What is Interpace Biosciences's CUSIP number?
Interpace Biosciences's Committee on Uniform Securities Identification Procedures number is: 46062X105
More guides on Finder
-
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
-
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
-
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert